Health Condition 1: K628- Other specified diseases of anus and rectum
Conditions
Interventions
Intervention1: NIL: NIL
Sponsors
NIL
Eligibility
Inclusion criteria
Inclusion criteria: consecutive patients with non-metastatic, histopathologically-proven rectal adenocarcinoma with significant lateral pelvic lymphadenopathy, undergoing elective curative-intent minimally-invasive (laparoscopic or robotic) TME or extended-TME and LPLND, regardless of the receipt of neoadjuvant therapy during the study period.
Exclusion criteria
Exclusion criteria: Patients with a history of having undergone pelvic surgery in the past, histologies other than adenocarcinoma, or presenting with locally-advanced tumors requiring adjacent organ resections or pelvic exenterations. Pateint with incomplete medical records
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| i.Postoperative morbidity ii.Positive margins (including CRM) iii.Median LPLN yield (IQR) iv.LPLN positivity rate v.Lateral Pelvic Recurrence rate vi.2-year Event-free Survival vii.2-year Overall Survival Timepoint: 2 years | — |
Secondary
| Measure | Time frame |
|---|---|
| i.Distribution of complications in the postoperative period. ii.Length of hospital stay iii.Intra-operative blood loss Timepoint: 2 years | — |
Countries
India
Contacts
Public ContactDr Avanish Saklani
Tata Memorial Hospital Dr. Ernest Borges Street, Parel, Mumbai (India)
Outcome results
None listed